Entirely GRAS Material-based Large Brain-Penetrating Nanoparticles for Widespread Therapeutic Distribution in Healthy and Tumor-bearing Brain Tissues

Case ID:
C15580

Unmet Need

Glioblastomas account for 45% of all brain cancers, and affect nearly 11,000 men, women and children every year. They are the most debilitating, complex, and treatment-resistant brain tumors. They can become widespread quickly and can grow in multiple areas at once making them difficult to remove completely using surgery or radiation therapy. Pharmaceutical therapies are also difficult to develop because the blood brain barrier prevents most drugs from entering the brain. One method to overcome the blood brain barrier is to use convection-enhanced diffusion (CED) to directly administer the therapeutics into the tumor, but recurrence of the tumor is still an issue and median patient life is still below 4 years at best. Combining CED with a novel drug delivery system has the potential of improving the administration of therapeutics using CED in brain tumors. There is a need for a vehicle that can facilitate long lasting, deeply penetrating, and widespread even distribution of therapeutics in the brain.


Technology Overview

Our invention is a generally recognized as safe (GRAS) nanoparticle with a non-adhesive coating administered using CED. The nanoparticle and method of administration facilitates larger diameter (up to 200 nm) nanoparticles to penetrate deeper into tissue and diffuse further throughout the brain. The advantages of our technology over others is the widespread distribution of the nanoparticles, the almost 100% tumor tissue penetration, and the larger size allowing for higher concentrations of the therapeutic.


Stage of Development

The distribution and penetration of the 60 – 200 nm nanoparticles demonstrated in brain tumor animal models.


Publication

Negron, Karina, et al. "A Highly Translatable Dual‐arm Local Delivery Strategy To Achieve Widespread Therapeutic Coverage in Healthy and Tumor‐bearing Brain Tissues.Small 19.11 (2023): 2207278. - https://doi.org/10.1002/smll.202207278

Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date Patent Status
NANOPARTICLES FOR DRUG DELIVERY TO BRAIN PCT: Patent Cooperation Treaty United States 17/602,664   10/8/2021     Pending
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Nakisha Holder
nickki@jhu.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum